515 related articles for article (PubMed ID: 18165645)
1. Health-related quality of life results in pathologic stage C prostate cancer from a Southwest Oncology Group trial comparing radical prostatectomy alone with radical prostatectomy plus radiation therapy.
Moinpour CM; Hayden KA; Unger JM; Thompson IM; Redman MW; Canby-Hagino ED; Higgins BA; Sullivan JW; Lemmon D; Breslin S; Crawford ED; Southwest Oncology Group
J Clin Oncol; 2008 Jan; 26(1):112-20. PubMed ID: 18165645
[TBL] [Abstract][Full Text] [Related]
2. Health-related quality of life 2 years after treatment with radical prostatectomy, prostate brachytherapy, or external beam radiotherapy in patients with clinically localized prostate cancer.
Ferrer M; Suárez JF; Guedea F; Fernández P; Macías V; Mariño A; Hervas A; Herruzo I; Ortiz MJ; Villavicencio H; Craven-Bratle J; Garin O; Aguiló F;
Int J Radiat Oncol Biol Phys; 2008 Oct; 72(2):421-32. PubMed ID: 18325680
[TBL] [Abstract][Full Text] [Related]
3. A prospective longitudinal study comparing the impact of external radiation therapy with radical prostatectomy on health related quality of life (HRQOL) in prostate cancer patients.
van Andel G; Visser AP; Zwinderman AH; Hulshof MC; Horenblas S; Kurth KH
Prostate; 2004 Mar; 58(4):354-65. PubMed ID: 14968436
[TBL] [Abstract][Full Text] [Related]
4. Quality of life outcomes after brachytherapy for early stage prostate cancer.
Brandeis JM; Litwin MS; Burnison CM; Reiter RE
J Urol; 2000 Mar; 163(3):851-7. PubMed ID: 10687991
[TBL] [Abstract][Full Text] [Related]
5. Utility and health-related quality of life in prostate cancer patients 12 months after radical prostatectomy or radiation therapy.
Krahn MD; Bremner KE; Tomlinson G; Naglie G
Prostate Cancer Prostatic Dis; 2009; 12(4):361-8. PubMed ID: 19901935
[TBL] [Abstract][Full Text] [Related]
6. Health related quality of life in Japanese men after radical prostatectomy or radiation therapy for localized prostate cancer.
Namiki S; Tochigi T; Kuwahara M; Ioritani N; Terai A; Numata I; Satoh M; Saito S; Koinuma N; Arai Y
Int J Urol; 2004 Aug; 11(8):619-27. PubMed ID: 15285752
[TBL] [Abstract][Full Text] [Related]
7. Five-year outcomes after prostatectomy or radiotherapy for prostate cancer: the prostate cancer outcomes study.
Potosky AL; Davis WW; Hoffman RM; Stanford JL; Stephenson RA; Penson DF; Harlan LC
J Natl Cancer Inst; 2004 Sep; 96(18):1358-67. PubMed ID: 15367568
[TBL] [Abstract][Full Text] [Related]
8. Determinants of long-term quality of life and voiding function of patients treated with radical prostatectomy or permanent brachytherapy for prostate cancer.
Bradley EB; Bissonette EA; Theodorescu D
BJU Int; 2004 Nov; 94(7):1003-9. PubMed ID: 15541117
[TBL] [Abstract][Full Text] [Related]
9. Gynecomastia and breast pain induced by adjuvant therapy with bicalutamide after radical prostatectomy in patients with prostate cancer: the role of tamoxifen and radiotherapy.
Di Lorenzo G; Perdonà S; De Placido S; D'Armiento M; Gallo A; Damiano R; Pingitore D; Gallo L; De Sio M; Autorino R
J Urol; 2005 Dec; 174(6):2197-203. PubMed ID: 16280763
[TBL] [Abstract][Full Text] [Related]
10. Radical prostatectomy for clinical T4 prostate cancer.
Johnstone PA; Ward KC; Goodman M; Assikis V; Petros JA
Cancer; 2006 Jun; 106(12):2603-9. PubMed ID: 16700037
[TBL] [Abstract][Full Text] [Related]
11. A randomized trial comparing radical prostatectomy plus endocrine therapy versus external beam radiotherapy plus endocrine therapy for locally advanced prostate cancer: results at median follow-up of 102 months.
Akakura K; Suzuki H; Ichikawa T; Fujimoto H; Maeda O; Usami M; Hirano D; Takimoto Y; Kamoto T; Ogawa O; Sumiyoshi Y; Shimazaki J; Kakizoe T;
Jpn J Clin Oncol; 2006 Dec; 36(12):789-93. PubMed ID: 17082219
[TBL] [Abstract][Full Text] [Related]
12. Health-related quality of life and satisfaction with care among older men treated for prostate cancer with either radical prostatectomy or external beam radiation therapy.
Jayadevappa R; Chhatre S; Whittington R; Bloom BS; Wein AJ; Malkowicz SB
BJU Int; 2006 May; 97(5):955-62. PubMed ID: 16643477
[TBL] [Abstract][Full Text] [Related]
13. Phase III multi-institutional trial of adjuvant chemotherapy with paclitaxel, estramustine, and oral etoposide combined with long-term androgen suppression therapy and radiotherapy versus long-term androgen suppression plus radiotherapy alone for high-risk prostate cancer: preliminary toxicity analysis of RTOG 99-02.
Rosenthal SA; Bae K; Pienta KJ; Sobczak ML; Asbell SO; Rajan R; Kerlin KJ; Michalski JM; Sandler HM;
Int J Radiat Oncol Biol Phys; 2009 Mar; 73(3):672-8. PubMed ID: 18990504
[TBL] [Abstract][Full Text] [Related]
14. A 3-y prospective study of health-related and disease-specific quality of life in patients with nonmetastatic prostate cancer treated with radical prostatectomy or external beam radiotherapy.
Yoshimura K; Arai Y; Ichioka K; Matsui Y; Ogura K; Terai A
Prostate Cancer Prostatic Dis; 2004; 7(2):144-51. PubMed ID: 15111981
[TBL] [Abstract][Full Text] [Related]
15. Radical prostatectomy versus high-dose rate brachytherapy for prostate cancer: effects on health-related quality of life.
Jo Y; Junichi H; Tomohiro F; Yoshinari I; Masato F
BJU Int; 2005 Jul; 96(1):43-7. PubMed ID: 15963118
[TBL] [Abstract][Full Text] [Related]
16. Quality of life after radical prostatectomy in Japanese men: 2 year longitudinal study.
Namiki S; Saito S; Satoh M; Ishidoya S; Kawamura S; Tochigi T; Kuwahara M; Aizawa M; Ioritani N; Yoshimura K; Ichioka K; Terai A; Arai Y
Jpn J Clin Oncol; 2005 Sep; 35(9):551-8. PubMed ID: 16141296
[TBL] [Abstract][Full Text] [Related]
17. Obesity adversely affects health related quality of life before and after radical retropubic prostatectomy.
Montgomery JS; Gayed BA; Hollenbeck BK; Daignault S; Sanda MG; Montie JE; Wei JT
J Urol; 2006 Jul; 176(1):257-61; discussion 261-2. PubMed ID: 16753415
[TBL] [Abstract][Full Text] [Related]
18. Phase III postoperative adjuvant radiotherapy after radical prostatectomy compared with radical prostatectomy alone in pT3 prostate cancer with postoperative undetectable prostate-specific antigen: ARO 96-02/AUO AP 09/95.
Wiegel T; Bottke D; Steiner U; Siegmann A; Golz R; Störkel S; Willich N; Semjonow A; Souchon R; Stöckle M; Rübe C; Weissbach L; Althaus P; Rebmann U; Kälble T; Feldmann HJ; Wirth M; Hinke A; Hinkelbein W; Miller K
J Clin Oncol; 2009 Jun; 27(18):2924-30. PubMed ID: 19433689
[TBL] [Abstract][Full Text] [Related]
19. The effect of postprostatectomy external beam radiotherapy on quality of life: results from the Cancer of the Prostate Strategic Urologic Research Endeavor.
Hu JC; Elkin EP; Krupski TL; Gore J; Litwin MS
Cancer; 2006 Jul; 107(2):281-8. PubMed ID: 16779794
[TBL] [Abstract][Full Text] [Related]
20. Prospective evaluation of quality of life in prostate cancer patients receiving combined treatment of postoperative radiotherapy plus androgen suppression for PT3 or positive resection margin after radical prostatectomy.
Choo R; Pearce A; Danjoux C; Morton G; Deboer G; Szumacher E; Loblaw A; Cheung P
Eur Urol; 2007 Dec; 52(6):1645-50. PubMed ID: 17140722
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
